KRT14 and anal carcinoma: In our previously established transgenic model of anal cancer, we observed that the constitutive expression of the HPV oncogenes E6 and E7 from a K14 promoter alone was not sufficient to induce disease or cancer and that treatment with the carcinogen DMBA was necessary (24).